India's tax department challenges Dr Lal PathLabs' tax relief for ₹32.66 crore in stock-option expenses

The Economic Times reports, citing a Dr Lal PathLabs regulatory filing, that India's Income Tax Department appealed to the Income Tax Appellate Tribunal in New Delhi. The appeal challenges an order granting relief over the disallowance of ₹32.66 crore in employee stock-option expenses for assessment year 2022–23. Dr Lal PathLabs says it does not reasonably expect the outcome to materially affect the company.